Børge G. Nordestgaard

Top papers

• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

  Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, et al.·2008·New England Journal of Medicine
  ↗ 6,590OA
• Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

  Brian A. Ference, Henry N. Ginsberg, Ian Graham, et al.·2017·European Heart Journal
  ↗ 3,733OA
• Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

  Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, et al.·2009·Obstetrical & Gynecological Survey
  ↗ 3,658
• Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

  Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries, et al.·2013·European Heart Journal
  ↗ 2,710OA
• Genome-wide association study identifies novel breast cancer susceptibility loci

  Douglas F. Easton, Karen A. Pooley, Alison M. Dunning, et al.·2007·Nature
  ↗ 2,334OA
• Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

  Børge G. Nordestgaard, Marianne Benn, Peter Schnohr, et al.·2007·JAMA
  ↗ 2,047
• Lipoprotein(a) as a cardiovascular risk factor: current status

  Børge G. Nordestgaard, M. John Chapman, Kausik K. Ray, et al.·2010·European Heart Journal
  ↗ 1,778OA
• Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

  Jan Borén, M. John Chapman, Ronald M. Krauss, et al.·2020·European Heart Journal
  ↗ 1,491OA
• Triglycerides and cardiovascular disease

  Børge G. Nordestgaard, Anette Varbo·2014·The Lancet
  ↗ 1,407
• Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

  Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, et al.·2015·European Heart Journal
  ↗ 1,399OA
• Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

  M. John Chapman, Henry N. Ginsberg, Pierre Amarenco, et al.·2011·European Heart Journal
  ↗ 1,221OA
• Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

  Florian Kronenberg, Samia Mora, Erik S.G. Stroes, et al.·2022·European Heart Journal
  ↗ 1,217OA